Matthias Wilhelm Selected Research

Matthias Wilhelm Research Topics

Disease

14	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2016
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2013
5	Heart Diseases (Heart Disease) 12/2021 - 06/2008
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
3	Atherosclerosis 01/2022 - 01/2021
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2021 - 06/2008
3	Cardiac Arrhythmias (Arrythmia) 12/2021 - 01/2019
3	Heart Failure 05/2021 - 06/2008
3	Acute Coronary Syndrome 01/2021 - 01/2019
3	Atrial Fibrillation 06/2015 - 02/2006
2	Neoplasms (Cancer) 12/2023 - 01/2023
2	ST Elevation Myocardial Infarction 01/2022 - 01/2022
2	Fibrosis (Cirrhosis) 01/2022 - 02/2006
2	Syncope (Fainting) 12/2021 - 01/2021
2	Tachycardia (Tachyarrhythmias) 01/2021 - 01/2019
2	Diabetes Mellitus 01/2021 - 01/2020
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2017 - 04/2016
2	Inflammation (Inflammations) 01/2017 - 08/2015
2	Atrial Remodeling 01/2016 - 04/2012
1	Second Primary Neoplasms (Neoplasms, Second) 12/2023
1	Left Ventricular Dysfunction 01/2023
1	Cardiotoxicity 01/2023
1	Frailty 01/2023
1	Iron Deficiencies 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Fatigue 01/2022
1	COVID-19 05/2021
1	Heart Valve Diseases (Valvular Heart Disease) 11/2020
1	Peripheral Arterial Disease 11/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Myocardial Infarction 01/2019
1	Insulin Resistance 01/2019
1	Shock 01/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2018
1	Congenitally Corrected Transposition of the Great Arteries 10/2017
1	Hypertension (High Blood Pressure) 06/2015

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 01/2021 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 04/2016
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2016
2	LDL CholesterolIBA 01/2021 - 01/2017
2	Insulin (Novolin)FDA Link 02/2017 - 04/2016
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2015
1	AnthracyclinesIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Ezetimibe (Zetia)FDA Link 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Clostridium perfringens epsilon-toxinIBA 01/2021
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2021
1	SubtilisinIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	lipoprotein cholesterolIBA 01/2020
1	GlycogenIBA 02/2017
1	FructoseIBA 02/2017
1	CholesterolIBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 04/2016
1	CytokinesIBA 01/2016
1	Atrial Natriuretic Factor (ANF)IBA 04/2012
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2008
1	Fish OilsIBA 06/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2008
1	Connexin 43 (Connexin43)IBA 02/2006
1	Gap Junction alpha-5 ProteinIBA 02/2006

Therapy/Procedure

15	Cardiac Rehabilitation 01/2023 - 10/2013
7	Therapeutics 12/2023 - 12/2019
6	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2021 - 06/2008
5	Secondary Prevention 01/2023 - 08/2015
4	Glycemic Control 01/2022 - 01/2020
3	Percutaneous Coronary Intervention 01/2022 - 01/2019
3	Endurance Training 09/2018 - 01/2014
2	Telerehabilitation 01/2023 - 05/2021
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2020 - 01/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Fitness Trackers 01/2022
1	Autonomic Denervation 01/2021
1	Patient Readmission 01/2021
1	Heart Transplantation (Grafting, Heart) 01/2021
1	Resuscitation 01/2019
1	Arterial Switch Operation 10/2017
1	Steam Bath (Sauna) 04/2016